Chugai, Gero partner to develop therapies for age-related diseases
Gero is a preclinical-stage biotechnology company that uses AI to develop therapeutics for age-related diseases. Its platform employs physics ...
Read the original at World Pharmaceutical Frontiers ↗
- Topics
- Healthcare
- Tracked via
- “that uses AI to”